Le Lézard
Classified in: Mining industry, Ebola virus
Subjects: CCA, ACC

SKF Half-year report to be published on 19 July


GOTHENBURG, Sweden, July 11, 2023 /PRNewswire/ -- SKF will publish its Half-year results for 2023 on 19 July at approximately 07:00 (CEST).

Investors, analysts, and media are invited to join a webcast, which will be held in English, at 08:15 (CEST).

To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers.

Link to web event: https://www.investis-live.com/skf/648982e267ddff0c002ef682/andn

Sweden                                +46 10 884 80 16
UK / International                 +44 20 3936 2999
Passcode:                            466190

All information regarding the results will be made available on the Group's IR website: https://investors.skf.com/en/reports-and-presentations 

Media: To book interviews with Rickard Gustafson, President and CEO, or Niclas Rosenlew, CFO, please contact Carl Bjernstam on [email protected].

Aktiebolaget SKF
(publ)

For further information, please contact:
PRESS: Carl Bjernstam, Head of Media Relations
tel: 46 31-337 2517; mobile: 46 722-201 893; e-mail: [email protected] 

INVESTOR RELATIONS: Patrik Stenberg, Head of Investor Relations
tel: 46 31-337 2104; mobile: 46 705-472 104; [email protected] 

The following files are available for download:

https://mb.cision.com/Main/637/3803150/2182690.pdf

20230711 SKF Half-year results to be published on 19 July

 


These press releases may also interest you

21 mar 2019
Europe's Welding Equipment Market: Growth, Trends and Forecasts (2019-2024) - ResearchAndMarkets.com
The "Europe Welding Equipment Market-Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering. Welding is one of the critical processes employed in the manufacturing...

21 mar 2019
Inovio's Ebola Vaccine Delivered Intradermally Demonstrates 100% Immunogenicity in a Clinical Study Published in The Journal of Infectious Diseases
Inovio Pharmaceuticals, Inc. announced today that its Ebola vaccine, INO-4201, was safe, tolerable, and generated strong T cell and antibody responses. This Phase 1 data was published in The Journal of Infectious Diseases and further supports the...

20 mar 2019
Merck and NGM Bio Announce Extension of Broad, Multi-Year Strategic Collaboration to 2022
Merck , known as MSD outside the United States and Canada, and NGM Biopharmaceuticals, Inc. (NGM) today announced that Merck has exercised its option to extend the research phase of the companies' broad, strategic collaboration...

20 mar 2019
Annual General Meeting of Sandvik Aktiebolag
The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Monday, 29 April 2019 at 3:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. RIGHT TO PARTICIPATE AND NOTICE Shareholders who wish to...

20 mar 2019
More Than the Bottom Line: Business for Peace Announces the 2019 Award Winners Celebrated for Delivering Opportunities for Women, Minorities and Diverse and Disadvantaged Groups
The Oslo Business for Peace Award is given to inspiring business leaders who have put society first. 2019's winners are: Dr Agbor Ashumanyi Ako, medical director of GiftedMom, Alice Laugher, CEO of Committed to...

19 mar 2019
Global Digital Business Support System Market is Expected to Grow at a CAGR of 15% by 2027 Owing to the Increasing Demand for Both Managed and Professional Services: Says Absolute Markets Insights
The evolving competitive market has made it essential for the telecommunication industry to rethink traditional ways of doing business in terms of the impact on business models, service portfolios and technical architectures. Digital business support...

More news about Ebola virus...


News published on and distributed by: